An interventional study of Routine Care and Experimental group intervention in Diabetes Mellitus and Peripheral Arterial Disease, sponsored by Second Affiliated Hospital of Nanchang University. Recruiting at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-19.
Sponsored by Second Affiliated Hospital of Nanchang University · Not applicable, Interventional, and Prevention
In this study, Logistic regression analysis was used to construct a risk prediction model for ASO in diabetic patients. Guided by the HAPA model, a nursing intervention plan for preventing ASO in diabetic patients was constructed and verified, with the aim of reducing the occurrence of ASO in diabetic patients and providing a reference for improving the quality of life of diabetic patients in clinical practice
11,089 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.
This study's planned enrollment of 154 is above the median of 80 across 8,491 interventional studies indexed under Diabetes Mellitus.
Browse Diabetes Mellitus studies →Second Affiliated Hospital of Nanchang University is the lead sponsor of 81 studies on the registry; 49 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The control group received routine care, namely admission education, routine care and education during hospitalization, unified health education at discharge, and routine follow-up after discharge.
Other: Routine Care
Based on the control group, the experimental group implemented the ASO prevention and nursing intervention program for diabetic patients based on the risk prediction model and the HAPA model
Behavioral: Experimental group intervention
Upon admission, the researcher and responsible nurse jointly assess the patient's condition, help the patient relax, introduce the hospital environment, ward routines, and relevant regulations, and the researcher guides the patient to complete the general information questionnaire. During hospitalization, the researcher first explains the causes and influencing factors of diabetes in a demonstration classroom, emphasizes healthy lifestyle habits, and advises smoking cessation and alcohol limitation. Next, dietary and exercise guidance is provided to both patients and their families. Finally, instruction is given on blood sugar monitoring and the importance of taking medication as prescribed.
Based on the control group, the experimental group implemented the ASO prevention and nursing intervention program for diabetic patients based on the risk prediction model and the HAPA model. The intervention was divided into four stages. The first stage was the pre-intention stage, in which face-to-face communication was adopted to improve patients' disease cognition. The second stage was the intention stage. This stage involves converting patients' behavioral intentions into practical actions through knowledge education, skill guidance, etc. The third stage is the action stage, where healthy behaviors are generated and maintained through providing social support, supervision and evaluation, etc.
ankle brachial index, ABI
Time frame: Collected respectively before the intervention and at 1, 3, and 6 months after the intervention
Summary of Diabetes Self Care Activities, SDSCA
This scale is used to assess the self-management ability of diabetic patients. It consists of 12 items, each of which is calculated on an 8-point scale ranging from 0 to 7. Individuals choose a score of 0 to 7 based on the number of days they have implemented it. The higher the score, the better the self-management ability. A score of 80 or above indicates good self-management ability, 60 to 80 indicates medium self-management ability, and below 60 indicates poor self-management ability.
Time frame: Collected respectively before the intervention and at 1, 3, and 6 months after the intervention
Diabetes Specific Quality of Life Scale, DSQL
DSQL is a specific quality of life scale designed for Chinese diabetic patients, consisting of 27 items in four dimensions: physiological, psychological, social and therapeutic. The total score ranges from 27 to 135 points. The higher the score, the worse the quality of life. The reference cut-off values are as follows: a score below 54 is considered good, 55 to 81 is medium, and a score above 82 indicates a poor quality of life. This scale has good reliability, validity and responsiveness, and is suitable for evaluating the current quality of life and intervention effects of Chinese diabetic patients.
Time frame: Collected respectively before the intervention and at 1, 3, and 6 months after the intervention
The Third Version of Diabetes Attitude Scale, DAS-3
The DAS-3 scale consists of five dimensions: Professional training needs, severity of type 2 diabetes, the value of strict blood sugar control, psychosocial impact and patient autonomy were scored using a 5-point Likert scale (1= strongly disagree, 5= strongly agree). Among them, the reverse scoring items needed to be converted to 6 minus the original score. The final score of each dimension was the average score of all items processed under that dimension. The higher the score, the more positive the attitude and the more in line with modern diabetes management concepts
Time frame: Collected respectively before the intervention and 1, 3, and 6 months after the intervention
Documents are hosted by the registry — open the source record to download them.
Plan to share: No
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Second Affiliated Hospital of Nanchang University